Related Experiment Video
Updated: Mar 6, 2026
06:08
Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
Published on: March 8, 2019
20.9K
HIF1α in aortic aneurysms and beyond.
Tomoki Hashimoto1, Victor Rizzo2
1Department of Anesthesia and Perioperative Care, Department of Neurological Surgery, University of California, San Francisco, U.S.A.
Clinical Science (London, England : 1979)
|March 18, 2017
Summary
This study confirms myeloid cells contribute to abdominal aortic aneurysm (AAA) development. Hypoxia-inducible factor-1α (HIF1α) in these cells is crucial for regulating vessel wall weakening, offering potential therapeutic targets.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Cellular Biology
Background:
- Abdominal aortic aneurysm (AAA) is a life-threatening condition characterized by aortic wall expansion, often leading to rupture with high mortality.
- Current treatment for AAA relies on surgical repair, highlighting the need for preventative and therapeutic strategies.
- Understanding the cellular and molecular drivers of AAA is critical for developing novel interventions.
Purpose of the Study:
- To investigate the role of myeloid cells in the pathogenesis of abdominal aortic aneurysm.
- To elucidate the specific molecular mechanisms by which myeloid cells influence AAA development and progression.
- To identify potential therapeutic targets within myeloid cell signaling pathways.
Main Methods:
- Utilized a murine model of AAA to study the contribution of myeloid cells.
- Investigated the role of hypoxia-inducible factor-1α (HIF1α) in myeloid cell function within the context of AAA.
- Analyzed the expression of extracellular matrix (ECM) modifying enzymes and their inhibitors in myeloid cells.
Main Results:
- Confirmed the significant contribution of myeloid cells to the development and progression of AAA.
- Demonstrated that HIF1α is essential for regulating the expression of ECM-modifying enzymes and their inhibitors in myeloid cells.
- Identified a critical link between HIF1α-mediated myeloid cell function and the degradation of the aortic vessel wall.
Conclusions:
- Myeloid cells play a pivotal role in AAA formation and growth.
- HIF1α is a key regulator of myeloid cell-induced extracellular matrix remodeling in AAA.
- Targeting HIF1α in myeloid cells presents a promising therapeutic strategy to prevent or limit AAA progression.
Related Concept Videos
01:30Aneurysm I: Introduction
562
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
562
01:15Aortic Regurgitation I: Introduction
955
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
955
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
449
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
449
01:26Aneurysm III: Interprofessional Care
414
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
414
01:24Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
714
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
714